Monique J. Roobol

Active 2002–2025

205
Papers
31,972
Citations
89
h-index
191
i10-index

Citations

Citations per year for Monique J. Roobol1961: 1 citations1978: 1 citations1985: 2 citations2003: 2 citations2004: 5 citations2005: 13 citations2006: 21 citations2007: 38 citations2008: 67 citations2009: 111 citations2010: 184 citations2011: 195 citations2012: 246 citations2013: 257 citations2014: 268 citations2015: 265 citations2016: 248 citations2017: 222 citations2018: 268 citations2019: 820 citations2020: 990 citations2021: 998 citations2022: 790 citations2023: 621 citations2024: 1,160 citations2025: 414 citations2026: 22 citations1962–1977: no citations, so these years are not shown1979–1984: no citations, so these years are not shown1986–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,028 citing papers, 20.9% of this breakdownUnited Kingdom: 871 citing papers, 9% of this breakdownChina: 763 citing papers, 7.9% of this breakdownNetherlands: 603 citing papers, 6.2% of this breakdownGermany: 554 citing papers, 5.7% of this breakdownItaly: 537 citing papers, 5.6% of this breakdownCanada: 500 citing papers, 5.2% of this breakdownFrance: 376 citing papers, 3.9% of this breakdownSweden: 309 citing papers, 3.2% of this breakdownAustralia: 291 citing papers, 3% of this breakdownSpain: 216 citing papers, 2.2% of this breakdownSwitzerland: 204 citing papers, 2.1% of this breakdown
0%20.9%Other 25.1%

Fields

  • Medicine79.1%
  • Biochemistry, Genetics and Molecular Biology11.9%
  • Computer Science2.3%
  • Engineering1.4%
  • Health Professions1.2%
  • Chemistry0.6%
  • Other3.5%

Topics

  • Prostate Cancer Diagnosis and Treatment20.8%
  • Prostate Cancer Treatment and Research17.2%
  • Urologic and reproductive health conditions3.1%
  • Global Cancer Incidence and Screening2.5%
  • AI in cancer detection2.4%
  • MRI in cancer diagnosis2.4%
  • Other51.6%

Coauthors

All papers

Open in search
  1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman Williams, Chris Brew‐Graves, Jonathan J Deeks, Yemisi Takwoingi, Mark Emberton, Caroline M. Moore - New England Journal of Medicine 2018 cited by 3,016

  2. Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators

    Authors: , , , , , , , - European Urology 2018 cited by 1,296

  3. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anssi Auvinen - European Urology 2019 cited by 698

  4. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

    Authors: , , , , , , - Cochrane Database of Systematic Reviews 2019 cited by 643

  5. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

    Authors: , , , , , - Nature Reviews Urology 2022 cited by 219

  6. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 1,565

  7. Screening and Prostate-Cancer Mortality in a Randomized European Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 4,014

  8. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

    Authors: , , , , , , - European Urology 2019 cited by 359

  9. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

    Authors: , , , , , , , - European Urology 2021 cited by 220

  10. Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI

    Authors: , , , , , , , - European Radiology 2020 cited by 115

  11. Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis

    Authors: , , , , , - European Urology 2014 cited by 697

  12. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

    Authors: , , , , , , , , , , , - European Urology 2018 cited by 195

  13. Prostate-Cancer Mortality at 11 Years of Follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,241

  14. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

    Authors: , , , , , , - European Urology 2016 cited by 397

  15. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2017 cited by 247

  16. Active Surveillance for Prostate Cancer: Past, Current, and Future Trends

    Authors: , , - Journal of Personalized Medicine 2023 cited by 45

  17. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Gross, Jeremy Grummet, Ann Henry, Alexandre Ingels, Jacques Irani, Michael Lardas, Matthew Liew, Daniel W. Lin, Lisa Moris, Muhammad Imran Omar, Karl H. Pang, Catherine Paterson, Raphaële Renard‐Penna, María J. Ribal, Monique J. Roobol, Morgan Rouprêt, Olivier Rouvière, Gemma Sancho, Jonathan Richenberg, Ivo G. Schoots, J.P. Michiel Sedelaar, Phillip D. Stricker, Derya Tilki, Susanne Vahr Lauridsen, Roderick C.N. van den Bergh, Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Geert J.L.H. van Leenders, Murali Varma, Philippe D. Violette, Christopher J.D. Wallis, Thomas Wiegel, Karen Wilkinson, Fabio Zattoni, James Michael Olu N'Dow, Hendrik Van Poppel, Philip Cornford, Nicolas Mottet - European Urology 2019 cited by 239

  18. A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer

    Authors: , , , , - European Urology 2023 cited by 68

  19. A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer

    Authors: , , , , , - European Urology Oncology 2021 cited by 105

  20. Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U

    Authors: , , - European Urology 2023 cited by 52

  21. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David V. Conti, Fredrik Wiklund, Stephen Chanock, Ying Wang, Victoria L. Stevens, Catherine M. Tangen, Jyotsna Batra, Judith A. Clements, APCB BioResource (Australian Prostate Cancer BioResource), Henrik Grönberg, Nora Pashayan, Johanna Schleutker, Demetrius Albanes, Stephanie Weinstein, Alicja Wolk, Catharine M. L. West, Lorelei A. Mucci, Géraldine Cancel-Tassin, Stella Koutros, Karina Dalsgaard Sørensen, Eli Marie Grindedal, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Ruth C. Travis, Robert J. Hamilton, Sue Ann Ingles, Barry S. Rosenstein, Yong-Jie Lu, Graham G. Giles, Adam S. Kibel, Ana Vega, Manolis Kogevinas, Kathryn L. Penney, Jong Y. Park, Janet L. Stanford, Cezary Cybulski, Børge G. Nordestgaard, Sune F. Nielsen, Hermann Brenner, Christiane Maier, Jeri Kim, Esther M. John, Manuel R. Teixeira, Susan L. Neuhausen, Kim De Ruyck, Azad Razack, Lisa F. Newcomb, Davor Lessel, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A. Townsend, Jose Esteban Castelao, Monique J. Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Stephen N. Thibodeau, David J. Hunter, Peter Kraft, William J. Blot, Elio Riboli, VA Million Veteran Program, Dipender Gill, Kostas K. Tsilidis - Diabetologia 2023 cited by 37

  22. A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy

    Authors: , , , , , , , , , , , , , , - British Journal of Urology 2017 cited by 135

  23. Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators

    Authors: , , , , , , , , - European Urology 2011 cited by 218

  24. Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers

    Authors: , , , , , , , - European Urology 2015 cited by 155